Table 2.
Patient characteristics at ICU admission
| Men | Women | p | |
|---|---|---|---|
| n = 57 | n = 95 | ||
| Age years | 60.5(57.6–63.4) | 56.3 (53.4–59.2) | 0.02 |
| Time between survey and sepsis years (median) | 7.8 (IQR 8.3) | 6.6 (IQR 8.1) | 0.16 |
| Disease scores | |||
| APACHE II Score | 18.2 (16.3–20.1) | 18.9 (17.4–20.3) | 0.57 |
| SOFA score | 7.0 (6.0–8.0) | 7.0 (6.2–7.8) | 0.95 |
| Disease severity n (%) | |||
| Sepsis | 17 (29.8) | 22 (23.2) | 0.44 |
| Severe sepsis | 32 (56.1) | 47 (49.5) | 0.50 |
| Septic shock | 8 (14.0) | 26 (27.4) | 0.07 |
| Hospital mortality | 13 (22.8) | 19 (20.0) | 0.69 |
| Co-morbidities n (%) | |||
| COPD | 1 (1.8) | 3 (3.2) | 1.00 |
| Congestive heart failure | 3 (5.3) | 2 (2.1) | 0.36 |
| Chronic renal insufficiency | 2 (3.5) | 2 (2.1) | 0.63 |
| Diabetes n (%) | |||
| Insulin treatment | 4 (7.0) | 7 (7.4) | 1.00 |
| Other treatments | 4 (7.0) | 5 (5.3) | 0.73 |
| Cancer n (%) | |||
| Hematological | 4 (7.0) | 5 (5.3) | 0.73 |
| Localized | 9 (15.8) | 11 (11.6) | 0.47 |
| Metastatic | 5 (8.8) | 6 (6.3) | 0.75 |
| Immunosuppressants n (%) | |||
| Chronic steroids | 3 (5.3) | 5 (5.3) | 1.00 |
| Chemotherapy | 7 (12.3) | 6 (6.3) | 0.24 |
| Other immunosuppression | 4 (7.0) | 7 (7.4) | 1.00 |
| Primary infection site n (%) | |||
| Pneumonia | 11 (19) | 13 (14) | 0.37 |
| Abdominopelvic | 19 (33) | 31 (33) | 1.00 |
| Urinary tract | 10 (18) | 11 (12) | 0.34 |
| Other | 17 (30) | 38 (40) | 0.23 |
| Unknown | 2 (3.5) | 3 (3.2) | 1.00 |
Values shown are means (95% CI), medians (IQR) and numbers (%)
Abbreviations: APACHE acute physiology, age and chronic health evaluation, SOFA sequential organ failure assessment, CI confidence interval, IQR interquartile range, COPD chronic obstructive pulmonary disease, ICU intensive care unit